DOI QR코드

DOI QR Code

Roles of White Blood Cells and Subtypes as Inflammatory Markers in Skin Cancer

  • Baykan, Halit (Department of Plastic and Reconstructive Surgery, Kayseri Education and Research Hospital) ;
  • Cihan, Yasemin Benderli (Department of Radiation Oncology, Kayseri Education and Research Hospital) ;
  • Ozyurt, Kemal (Department of Dermatology, Kayseri Education and Research Hospital)
  • 발행 : 2015.04.03

초록

Objective: Skin tumors are the most commonly seen cancer type worldwide. Regarding pathogenesis, it is thought that disruption of kinetics through T lymphocyte-mediated development of chronic inflammation may be involved. The present study was intended to identify role of inflammatory cells such as neutrophils, monocytes and lymphocytes in the determination of risk for skin cancer. Materials and Methods: We retrospectively reviewed charts of 569 cases diagnosed as having primary skin tumors. Data regarding age, gender and histopathological subtype were recorded. Blood parameters studied on the day before surgery including WBCs, neutrophils, and lymphocyte counts, neutrophil:lymphocyte and neutrophil:monocyte ratios were also recorded. Two-hundred and two healthy individuals presented for check-up in an outpatient clinic were selected as the control group. Parameters studied in cases with skin cancer were compared to those healthy individuals. Findings: Of the cases with skin cancer, 401 were basal cell carcinoma (BCC) while 144 were squamous cell carcinoma (SCC) and 13 were malignant melanoma (MM). WBC, neutrophil and monocyte counts and the neutrophil:lymphocyte ratio were found to be lower in the patient group than in the healthy control group (p<0.001) while no significant difference was found in other parameters reviewed (p>0.05). No significant difference was found in WBC, neutrophil, neutrophil: monocyte ratio according to gender (p>0.05). Monocyte count was found to be $0.68{\pm}0.61$ in men and $0.55{\pm}0.25$ in women, indicating strong statistical significance (p<0.001). WBC, neutrophil and monocyte values were highest in control group while lowest in BCC. When BCC and SCC groups were compared to controls, significant differences found (p<0.001). There were no significant differences in lymphocyte counts among groups (p=0.976). Neutrophil:lymphocyte ratios were 3.24 in BCC, 3.59 in SCC, 3.44 in MM and 5.06 in control group (p<0.001). Conclusions: In our study, it was found that there were significant differences in complete blood count, neutrophil, monocyte and neutrophil:lymphocyte levels among groups. Neutrophil: lymphocyte ratio was found to be lowest in BCC among skin cancers.

키워드

참고문헌

  1. Ardies CM (2003). Inflammation as cause for scar cancers of the lung. Integr Cancer Ther, 2, 238-46. https://doi.org/10.1177/1534735403256332
  2. Benderli Cihan Y, Baykan H, Kavuncuoglu E, et al (2013). Relationships between skin cancers and blood groups -link between non-melanomas and ABO/Rh factors. Asian Pac J Cancer Prev, 14, 4199-203. https://doi.org/10.7314/APJCP.2013.14.7.4199
  3. Bo Wook Kim, Young Eun Jeon, Hanbyoul Cho, et al (2012). Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte. J Obstet Gynaecol Res, 38, 48-56. https://doi.org/10.1111/j.1447-0756.2011.01694.x
  4. Cancer incidence in five continents (2002). Lyon: International agency for research on cancer, Vol VIII, p. 234-240
  5. Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7. https://doi.org/10.1038/nature01322
  6. Fridlender ZG, Albelda SM (2012). Tumor-associated neutrophils: friend or foe? Carcinogenesis, 33, 949-55. https://doi.org/10.1093/carcin/bgs123
  7. Gregory AD, Houghton AM (2011). Tumor-Associated Neutrophils: New Targets for Cancer Therapy. Cancer Res, 71, 2411-6. https://doi.org/10.1158/0008-5472.CAN-10-2583
  8. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA: Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  9. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancer-related inflammation. Nature, 454, 436-444. https://doi.org/10.1038/nature07205
  10. Marcil I, Stern RS (2000). Risk of developing a subsequent non-melanoma skin cancer in patients with a history of non-melanoma skin cancer. Arc Dermal, 136, 1524-30.
  11. Margolis KL, Rodabough RJ, Thomson CA, Lopez AM, McTiernan A (2007). Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women. Arch Intern Med, 167, 1837-44. https://doi.org/10.1001/archinte.167.17.1837
  12. Mantovani A, Allavena P, Sica A, Balkwill F (2008). Cancer-related inflammation. Nature, 454, 436-44. https://doi.org/10.1038/nature07205
  13. Miller DL, Weinstock MA (1994). Cancer head and neck-2 nonmelanoma skin cancer in the United States; incidence. J Am Acad Dermatol, 30, 774. https://doi.org/10.1016/S0190-9622(08)81509-5
  14. Nathan C (2006). Neutrophils and immunity: challenges and opportunities. Nat Rev Immunol, 6, 173-82. https://doi.org/10.1038/nri1785
  15. Parker S, Tong T, Bolden S, et al (1996). Cancer statistics 1996. Cancer J Clin, 4, 61-5.
  16. Sparmann A, Bar-Sagi D (2004). Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell, 6, 447-58. https://doi.org/10.1016/j.ccr.2004.09.028
  17. Wislez M, Rabbe N, Marchal J, et al (2003). Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res, 63, 1405-12.

피인용 문헌

  1. May the Neutrophil/Lymphocyte Ratio Be a Predictor in the Differentiation of Different Thyroid Disorders? vol.16, pp.9, 2015, https://doi.org/10.7314/APJCP.2015.16.9.3875
  2. Zusammenhang zwischen Thrombozyten-Lymphozyten-Quotient und Neutrophilen-Monozyten-Quotient sowie radiologischem Grad der Gonarthrose pp.1435-1250, 2017, https://doi.org/10.1007/s00393-017-0348-7
  3. CD58; leucocyte function adhesion-3 (LFA-3) could be used as a differentiating marker between immune and non-immune thyroid disorders vol.27, pp.3, 2018, https://doi.org/10.1007/s00580-018-2657-x